CellAegis Devices Inc. — Form D/A
CellAegis Devices Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2017-03-10. The offering totals $3.1M, of which $3.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-03-10
- Form: D/A
- Accession: 0001573661-17-000011
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.1M
- Amount sold: $3.1M
- Investors: 5
- Date of first sale: 2017-03-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-282186
Issuer
- Name: CellAegis Devices Inc.
- CIK: 0001573661
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2011
- Address: 139 MULOCK AVE., 1ST FLOOR, TORONTO, A6, M6N 1G9
- Phone: (647) 722-9601
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| John Berton | Director | TORONTO, A6 |
| Chris Colecchi | Director | Boston, MA |
| Rocky Ganske | Director | Toronto, A6 |
| Eric Knudsen | Director | Chelmsford, MA |
| Donna Parr | Director | Auburndale, MA |
| Brian Roberts | Director | New York, NY |
| Shermaine Tilley | Director | Vancouver, A1 |
| John Berton | Executive Officer | TORONTO, A6 |
| Rocky Ganske | Executive Officer | Toronto, A6 |
| Donna Parr | Executive Officer | Auburndale, MA |
| Henry Kay | Director | Farmington, CT |
| Chris Caldarone | Director | Toronto, A6 |
| Andrew Redington | Director | Toronto, A6 |
Other filings by this issuer (14)
More